SEC Tracker
Get the app

First Light Acquisition Group CLDI

First Light Acquisition Group FY 2022: revenue $45K; diluted EPS $2.99

Form
10-K
Filed
Period
Importance
Notable
Document
10-K
Exhibit 10.22
Material contract
Exhibit 10.23
Material contract

Key figures from this report

These are the numbers First Light Acquisition Group reported for the year ended Dec 31, 2022, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$45KNo year-earlier figure tagged10-K income statement, on EDGAR
  2. Net income$3.5MNo year-earlier figure tagged10-K income statement, on EDGAR
  3. Diluted EPS$2.99No year-earlier figure tagged10-K income statement, on EDGAR
  4. Cash and cash equivalents$94K−91% from $1.1M in FY 202110-K balance sheet, on EDGAR
  5. Cash from operations$98KNo year-earlier figure tagged10-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when First Light Acquisition Group files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Processa Pharmaceuticals PCSA public float $8M, Jun 30, 2025
  2. Talphera TLPH public float $8M, Jun 30, 2025
  3. Orgenesis ORGS public float $8M, Jun 30, 2025
  4. Biovie BIVI public float $8M, Dec 31, 2025
  5. VivoSim Labs VIVS public float $8M, Sep 30, 2025